drugset / Trial / NCT01276548
A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer.
Timeline
- Start
- 2009-10
- Primary completion
- 2012-05
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | — |
| Comparator | Paclitaxel | Small molecule | 260 mg/m2 | — |
| Background | Carboplatin | Small molecule | 5 unknown | — |